Vyera Pharmaceuticals, LLC Email Format

Pharmaceutical ManufacturingNew York, United States2-10 Employees

Vyera Pharmaceuticals, LLC operates in the pharmaceutical manufacturing sector with a focus on developing and commercializing treatments for serious and neglected diseases that have high unmet needs. The company emphasizes options for toxoplasmosis and other rare or serious health conditions, aiming to address therapeutic gaps for patients and healthcare providers. Based in New York City, Vyera has historically been involved in positioning itself within a niche of high-need infectious and rare disease markets, and it has engaged in activities related to drug pricing and competition oversight in the past. The firm’s public-facing profile notes a small organizational footprint, and it remains active in pursuing treatment development and commercialization within its specialized portfolio. A recent development noted in coverage is Vyera’s historical acquisition activity related to its Daraprim portfolio, reflecting its ongoing involvement in legacy drugs and related regulatory scrutiny.

Sign up for free to view info

Company overview Employee directory